NREL: 2020 was year of highlights for energy lab

NREL: 2020 was year of highlights for energy lab

GOLDEN -- National Renewable Energy Laboratory (NREL) researchers and staff reached many goals and achieved numerous successes in science, partnerships, and technology commercialization in 2020, from... Read More

Wednesday December 23, 2020 0 comments Tags: Golden, NREL

Alpha Data announces Xilinx Versal ACAP accelerator board

Alpha Data announces Xilinx Versal ACAP accelerator board

GOLDEN and EDINBURGH, Scotland -- Alpha Data , a leading supplier of commercial off-the shelf FPGA solutions, announced the release of the ADM-PA100, the first deployable adaptive computing... Read More

Friday November 20, 2020 0 comments Tags: Golden, Alpha Data, Xilinx, Manuel Uhm , ADM-PA100

NREL: Advanced manufacturing research moves wind turbine blades toward recyclability

NREL: Advanced manufacturing research moves wind turbine blades toward recyclability

GOLDEN -- A new material for wind blades that can be recycled could transform the wind industry, rendering renewable... Read More

Wednesday November 18, 2020 0 comments Tags: Golden, NREL, wind power, Derek Berry

Reven Pharmaceuticals reports positive results regarding clinical safety and preclinical efficacy of Its COVID-19 drug candidate Rejuveinix

Reven Pharmaceuticals reports positive results regarding clinical safety and preclinical efficacy of Its COVID-19 drug candidate Rejuveinix

GOLDEN -- Reven Holdings, Inc. today announced publication of a peer-reviewed article in the prestigious medical journal, Frontiers in Pharmacology, Section: Respiratory Pharmacology. In the... Read More

Thursday November 12, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, COVID-19, Rejuveinix, Fatih Uckun, Peter Lange, Brian Denomme

Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix

Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix

GOLDEN -- Reven today announced the U.S. Food and Drug Administration has approved its Investigational New Drug application in connection with its lead anti-inflammatory/anti-oxidant... Read More

Thursday October 22, 2020 0 comments Tags: Golden, Reven Pharmaceuticals, Reven Holdings, Rejuveinix, COVID-19, Fatih Uckun, Michael Volk, Peter Lange

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More

Wednesday September 30, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, DSG, Fatih Uckun, Michael Volk, Tony Varano, COVID-19

Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients

Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients

GOLDEN -- Reven Holdings, a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral... Read More

Tuesday September 15, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, COVID-19, Michael Volk, Fatih Uckun, Rejuveinix